Fibriant and Biomed Elements have entered into a research collaboration, combining their fibrinogen and biopolymer technologies, to develop a topical hemostat product for stopping severe life-threatening bleeding in the pre-hospital setting.
Fibriant and Biomed Elements announce collaboration to develop a new topical hemostat product to stop severe bleeding supported by a MIT grant from the province of Zuid Holland, The Netherlands.
Comments are closed.